Access cutting-edge head and neck cancer treatment through this clinical trial at a research site in Indianapolis. Study-provided care at no cost to qualified participants.
Access head and neck cancer specialists in Indianapolis at no cost
This study follows strict safety protocols and ethical guidelines
All study-related head and neck cancer treatment provided free
The purpose of this research study is to evaluate the effectiveness of using a combination of pembrolizumab and olaparib when given before and after standard chemoradiation therapy in treating locally advanced head and neck squamous cell carcinoma. Pembrolizumab and olaparib are drugs that are approved for head and neck cancer treatment. However, FDA has not approved the use of these two drugs together in treating head and neck cancer.
Sponsor: UNC Lineberger Comprehensive Cancer Center
Check if you qualify for this head and neck cancer clinical trial in Indianapolis, IN
If you're searching for head and neck cancer treatment options in Indianapolis, IN, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Indianapolis research site is actively enrolling participants for this clinical trial. You'll receive care from experienced head and neck cancer specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.